echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JAMA Surg: The screening rate for primary aldosteronism in hypertensive patients is less than 1%

    JAMA Surg: The screening rate for primary aldosteronism in hypertensive patients is less than 1%

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Primary aldosteronism (PA) due to excessive secretion of adrenal aldosterone, resulting in vivo sodium retention, potassium row, increased blood volume, the renin - vascular angiotensin system activity inhibition, clinical manifestations of hypertension associated with hypokalemia , Accounting for about 10% of clinically hypertensive patients.


    Vascular medsci.


    Recently, researchers investigated the evaluation and treatment rate of primary aldosteronism in medical institutions in Canada.


    Recently, researchers investigated the evaluation and treatment rate of primary aldosteronism in medical institutions in Canada.


    This study was conducted in Alberta, Canada.


    Screening

    A total of 1.


    Only 7941 people (0.


    PA screening rate and positive rate in hypertensive population

    The study found that among adults with hypertension in Alberta, Canada, less than 1% of patients with primary aldosteronism are expected to be formally diagnosed and treated.


    Only less than 1% of patients with primary aldosteronism are expected to be formally diagnosed and treated.


    Original source:

    Yuan-yuan Liu et al.


    com/journals/jamasurgery/article-abstract/2777912" target="_blank" rel="noopener">Outcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary Aldosteronism.
    JAMA

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.